Chemed (CHE) Releases FY19 Earnings Guidance

Chemed (NYSE:CHE) updated its FY19 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $12.65-12.85 for the period, compared to the Thomson Reuters consensus estimate of $12.78. Chemed also updated its FY 2019 guidance to $12.65-12.85 EPS.

Several analysts have issued reports on the company. Zacks Investment Research lowered Chemed from a hold rating to a sell rating in a research note on Thursday, May 9th. ValuEngine lowered Chemed from a buy rating to a hold rating in a research note on Wednesday, May 1st. Oppenheimer upped their price objective on Chemed from $340.00 to $370.00 and gave the company an outperform rating in a research note on Tuesday, April 30th. Finally, Royal Bank of Canada increased their target price on Chemed from $313.00 to $318.00 and gave the stock a sector perform rating in a research note on Monday, February 25th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. The company currently has a consensus rating of Hold and a consensus price target of $347.00.

NYSE:CHE traded down $2.56 during trading hours on Tuesday, reaching $329.33. 117,708 shares of the company were exchanged, compared to its average volume of 128,379. The company has a market capitalization of $5.33 billion, a P/E ratio of 27.61, a P/E/G ratio of 2.97 and a beta of 1.18. Chemed has a 1-year low of $260.03 and a 1-year high of $335.99. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.73 and a quick ratio of 0.70.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Monday, April 29th. The company reported $2.92 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $2.96 by ($0.04). The company had revenue of $462.03 million for the quarter, compared to analyst estimates of $468.28 million. Chemed had a return on equity of 35.19% and a net margin of 11.37%. The company’s quarterly revenue was up 5.2% compared to the same quarter last year. During the same period in the prior year, the company earned $2.72 EPS. On average, sell-side analysts anticipate that Chemed will post 12.65 EPS for the current fiscal year.

In other news, Director George J. Walsh III sold 1,000 shares of the stock in a transaction on Monday, February 25th. The stock was sold at an average price of $328.07, for a total value of $328,070.00. Following the completion of the transaction, the director now directly owns 7,663 shares in the company, valued at approximately $2,514,000.41. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Kevin J. Mcnamara sold 6,000 shares of the stock in a transaction on Monday, May 6th. The shares were sold at an average price of $331.67, for a total value of $1,990,020.00. Following the completion of the transaction, the insider now owns 159,334 shares of the company’s stock, valued at $52,846,307.78. The disclosure for this sale can be found here. In the last ninety days, insiders sold 21,245 shares of company stock worth $6,955,533. Company insiders own 3.96% of the company’s stock.

WARNING: This report was originally reported by Rockland Register and is the property of of Rockland Register. If you are reading this report on another publication, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this report can be read at

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.

Featured Story: Swap

Earnings History and Estimates for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with's FREE daily email newsletter.